Literature DB >> 26943180

Testing for the cytosine insertion in the VNTR of the MUC1 gene in a cohort of Italian patients with autosomal dominant tubulointerstitial kidney disease.

Claudio Musetti1, Deepak Babu2, Ileana Fusco2, Simona Mellone2, Andrea Zonta2, Marco Quaglia3, Vincenzo Cantaluppi3, Piero Stratta3, Mara Giordano2.   

Abstract

INTRODUCTION: Medullary cystic kidney disease type 1 (MCKD1; OMIM #174000) is a familial progressive tubule-interstitial nephropathy belonging to the recently defined group of autosomal dominant tubulointerstitial kidney diseases (ADTKD). CASE REPORT: A specific type of cytosine insertion in the extracellular variable number tandem repeat (VNTR) domain of the MUC1 gene causing the disease was tested in a group of 21 families with ADTKD. We identified this type of MUC1 mutation in two families, whose affected members are described in detail in this case report. Affected (ADTKD-MUC1) members developed end-stage renal disease (ESRD) with a higher incidence (p = 0.033) and at a younger age (p = 0.013) than probands with ADTKD but without this type of mutation. All patients with MUC1-associated kidney disease shared a rather unspecific tubule-interstitial laboratory pattern without medullary cysts, leading to ESRD between the age of 33 and 47 years. We were not able to identify any single common extra-renal feature among affected patients, even if they had various comorbidities, which are described in detail.
CONCLUSIONS: We identified this type of MUC1 mutation in 9.5 % of families from an ADTKD Italian cohort; larger studies are needed to better define the criteria for genetic testing for this type of mutation.

Entities:  

Keywords:  Autosomal-dominant tubule-interstitial kidney disease; MUC1; Malignancy; Medullary cystic kidney disease

Mesh:

Substances:

Year:  2016        PMID: 26943180     DOI: 10.1007/s40620-016-0282-9

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  13 in total

1.  Cloning and sequencing of a human pancreatic tumor mucin cDNA.

Authors:  M S Lan; S K Batra; W N Qi; R S Metzgar; M A Hollingsworth
Journal:  J Biol Chem       Date:  1990-09-05       Impact factor: 5.157

2.  Medullary cystic kidney disease type 1: mutational analysis in 37 genes based on haplotype sharing.

Authors:  Matthias T F Wolf; Bettina E Mucha; Hans C Hennies; Massimo Attanasio; Franziska Panther; Isabella Zalewski; Stephanie M Karle; Edgar A Otto; C Constantinou Deltas; Arno Fuchshuber; Friedhelm Hildebrandt
Journal:  Hum Genet       Date:  2006-04-26       Impact factor: 4.132

3.  Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1.

Authors:  Anthony J Bleyer; Stanislav Kmoch; Corinne Antignac; Vicki Robins; Kendrah Kidd; John R Kelsoe; Gerald Hladik; Philip Klemmer; Stephen J Knohl; Steven J Scheinman; Nam Vo; Ann Santi; Alese Harris; Omar Canaday; Nelson Weller; Peter J Hulick; Kristen Vogel; Frederick F Rahbari-Oskoui; Jennifer Tuazon; Constantinos Deltas; Douglas Somers; Andre Megarbane; Paul L Kimmel; C John Sperati; Avi Orr-Urtreger; Shay Ben-Shachar; David A Waugh; Stella McGinn; Anthony J Bleyer; Katerina Hodanová; Petr Vylet'al; Martina Živná; Thomas C Hart; P Suzanne Hart
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 8.237

Review 4.  MUC1: a novel metabolic master regulator.

Authors:  Kamiya Mehla; Pankaj K Singh
Journal:  Biochim Biophys Acta       Date:  2014-01-11

5.  Chronic renal failure of unknown origin is caused by HNF1B mutations in 9% of adult patients: a single centre cohort analysis.

Authors:  Claudio Musetti; Marco Quaglia; Simona Mellone; Alessia Pagani; Ileana Fusco; Alice Monzani; Mara Giordano; Piero Stratta
Journal:  Nephrology (Carlton)       Date:  2014-04       Impact factor: 2.506

6.  Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin.

Authors:  Arif B Ekici; Thomas Hackenbeck; Vincent Morinière; Andrea Pannes; Maike Buettner; Steffen Uebe; Rolf Janka; Antje Wiesener; Ingo Hermann; Sina Grupp; Martin Hornberger; Tobias B Huber; Nikky Isbel; George Mangos; Stella McGinn; Daniela Soreth-Rieke; Bodo B Beck; Michael Uder; Kerstin Amann; Corinne Antignac; André Reis; Kai-Uwe Eckardt; Michael S Wiesener
Journal:  Kidney Int       Date:  2014-03-26       Impact factor: 10.612

Review 7.  Hereditary interstitial kidney disease.

Authors:  Anthony J Bleyer; P Suzanne Hart; Stanislav Kmoch
Journal:  Semin Nephrol       Date:  2010-07       Impact factor: 5.299

8.  Unexpectedly high prevalence of rare genetic disorders in kidney transplant recipients with an unknown causal nephropathy.

Authors:  Marco Quaglia; Claudio Musetti; Gian Marco Ghiggeri; Giovanni Battista Fogazzi; Fabio Settanni; Renzo Luciano Boldorini; Elisa Lazzarich; Andrea Airoldi; Cristina Izzo; Mara Giordano; Piero Stratta
Journal:  Clin Transplant       Date:  2014-07-18       Impact factor: 2.863

9.  Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Authors:  Kai-Uwe Eckardt; Seth L Alper; Corinne Antignac; Anthony J Bleyer; Dominique Chauveau; Karin Dahan; Constantinos Deltas; Andrew Hosking; Stanislav Kmoch; Luca Rampoldi; Michael Wiesener; Matthias T Wolf; Olivier Devuyst
Journal:  Kidney Int       Date:  2015-03-04       Impact factor: 10.612

10.  Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing.

Authors:  Andrew Kirby; Andreas Gnirke; David B Jaffe; Veronika Barešová; Nathalie Pochet; Brendan Blumenstiel; Chun Ye; Daniel Aird; Christine Stevens; James T Robinson; Moran N Cabili; Irit Gat-Viks; Edward Kelliher; Riza Daza; Matthew DeFelice; Helena Hůlková; Jana Sovová; Petr Vylet'al; Corinne Antignac; Mitchell Guttman; Robert E Handsaker; Danielle Perrin; Scott Steelman; Snaevar Sigurdsson; Steven J Scheinman; Carrie Sougnez; Kristian Cibulskis; Melissa Parkin; Todd Green; Elizabeth Rossin; Michael C Zody; Ramnik J Xavier; Martin R Pollak; Seth L Alper; Kerstin Lindblad-Toh; Stacey Gabriel; P Suzanne Hart; Aviv Regev; Chad Nusbaum; Stanislav Kmoch; Anthony J Bleyer; Eric S Lander; Mark J Daly
Journal:  Nat Genet       Date:  2013-02-10       Impact factor: 38.330

View more
  4 in total

1.  Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease.

Authors:  Martina Živná; Kendrah Kidd; Anna Přistoupilová; Veronika Barešová; Mathew DeFelice; Brendan Blumenstiel; Maegan Harden; Peter Conlon; Peter Lavin; Dervla M Connaughton; Hana Hartmannová; Kateřina Hodaňová; Viktor Stránecký; Alena Vrbacká; Petr Vyleťal; Jan Živný; Miroslav Votruba; Jana Sovová; Helena Hůlková; Victoria Robins; Rebecca Perry; Andrea Wenzel; Bodo B Beck; Tomáš Seeman; Ondřej Viklický; Sylvie Rajnochová-Bloudíčková; Gregory Papagregoriou; Constantinos C Deltas; Seth L Alper; Anna Greka; Anthony J Bleyer; Stanislav Kmoch
Journal:  J Am Soc Nephrol       Date:  2018-07-02       Impact factor: 10.121

2.  Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations.

Authors:  Andrea Wenzel; Janine Altmueller; Arif B Ekici; Bernt Popp; Kurt Stueber; Holger Thiele; Alois Pannes; Simon Staubach; Eduardo Salido; Peter Nuernberg; Richard Reinhardt; André Reis; Patrick Rump; Franz-Georg Hanisch; Matthias T F Wolf; Michael Wiesener; Bruno Huettel; Bodo B Beck
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

3.  Genetic Testing of the mucin 1 gene-Variable Number Tandem Repeat Single Cytosine Insertion Mutation in a Chinese Family with Medullary Cystic Kidney Disease.

Authors:  Nuo Si; Ke Zheng; Jie Ma; Xiao-Lu Meng; Xue-Mei Li; Xue Zhang
Journal:  Chin Med J (Engl)       Date:  2017-10-20       Impact factor: 2.628

4.  Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland.

Authors:  S Cormican; D M Connaughton; C Kennedy; S Murray; M Živná; S Kmoch; N K Fennelly; P O'Kelly; K A Benson; E T Conlon; G Cavalleri; C Foley; B Doyle; A Dorman; M A Little; P Lavin; K Kidd; A J Bleyer; P J Conlon
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.